Remove 2016 Remove Clinical Trials Remove Marijuana Remove Treatment
article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” percent in 2016).” percent in 2016).”

article thumbnail

1 in 5 Parkinson’s Patients Use Cannabis

CannaMD

A new study indicates that a significant number of persons suffering from Parkinson’s disease use medical marijuana for symptom relief. The goal of the study was to gain a better understanding of not only the frequency of marijuana use by those suffering from Parkinson’s, but also their motivations for use and their experiences.

Patients 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

Japan has some of the harshest drug policies on Earth, including for cannabis — and is one of the worst places on Earth to get arrested on marijuana possession charges. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. What marijuana products are allowed in Japan?

Law 137
article thumbnail

Pain Relief: Marijuana vs. Opioids

CannaMD

Marijuana has long been used for pain in medical traditions around the world. Today, both patient experience and modern scientific research support claims of medical marijuana’s effectiveness for pain management. It is also known that marijuana targets the body’s pain receptors in ways similar to synthetic opioids.

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. Trial of Psilocybin Versus Escitalopram for Depression , 384 New England J.

article thumbnail

Medical cannabis studies offer hope to opioid users

Healer

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant.